About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Dkc1tm1Ppp
targeted mutation 1, Pier Paolo Pandolfi
MGI:2449175
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
 		Dkc1tm1Ppp/Dkc1+ involves: 129S1/Sv MGI:2654712
ot2
 		Dkc1tm1Ppp/Y involves: 129S1/Sv MGI:2661986


Genotype
MGI:2654712
ht1
Allelic
Composition		 Dkc1tm1Ppp/Dkc1+
Genetic
Background		 involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dkc1tm1Ppp mutation (0 available); any Dkc1 mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
abnormal definitive hematopoiesis ( J:81054 )
• although most phenotypic analyses were performed on G2 male hemizygotes, authors state that G1-G2 female heterozygotes display features of bone marrow failure at a lower penetrance, consistent with the observation that some human female carriers exhibit features of X-linked dyskeratosis congenita; however, no data are presented in J:81054

immune system

respiratory system

renal/urinary system

neoplasm

cellular

integument

Mouse Models of Human Disease
 DO ID OMIM ID(s) Ref(s)
dyskeratosis congenita DOID:2729 OMIM:PS127550
 J:81054




Genotype
MGI:2661986
ot2
Allelic
Composition		 Dkc1tm1Ppp/Y
Genetic
Background		 involves: 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dkc1tm1Ppp mutation (0 available); any Dkc1 mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
endocrine/exocrine glands
increased pheochromocytoma incidence ( J:81054 )
• ~4% of G1-G2 male hemizygotes (17-22 months of age) develop pheochromocytomas versus 0% of wild-type mice (20-24 months of age)
increased mammary adenocarcinoma incidence ( J:81054 )
• ~4% of G1-G2 male hemizygotes (17-22 months of age) develop mammary adenocarcinomas versus 0% of wild-type mice (20-24 months of age)

hematopoietic system
decreased common myeloid progenitor cell number ( J:81054 )
• in some cases, anemic G1 and G2 male hemizygotes display a decrease in myeloid cells, as revealed in BM cytospin preparations
extramedullary hematopoiesis ( J:81054 )
• G1 male hemizygotes exhibit extramedullary hematopoieis associated with splenomegaly
anemia ( J:81054 )
• starting at 6 months of age, ~60% of G1 and G2 male hemizygotes display severe anemia
decreased bone marrow cell number ( J:81054 )
• at 8 months of age, anemic G1 and G2 male hemizygotes show a mean BM cellularity of 67.8 7.1% versus 87.3 5.7% in wild-type control mice
decreased erythroid progenitor cell number ( J:81054 )
• at 8 months of age, anemic G1 and G2 male hemizygotes show a decrease in erythroid cells (CD71 and TER119 double-positive cells), as revealed by flow cytometric analysis
• BM colony-forming assays indicate a significant reduction of erythroid colony-forming units (CFU-Es) relative to wild-type control mice
decreased hemoglobin content ( J:81054 )
• at 8 months of age, ~60% of G1 and G2 male hemizygotes exhibit a mean hemoglobin of 10.6 4 g/dl versus 15.1 1.7 g/dl in wild-type mice
thrombocytopenia ( J:81054 )
• some G1 and G2 male hemizygotes exhibit reduced platelet counts relative to wild-type control mice
decreased leukocyte cell number ( J:81054 )
• starting at 6 months of age, ~60% of G1 and G2 male hemizygotes become mildly leukopenic as a result of lymphopenia, with a mean white blood cell count of 4526 3311 per l versus 8215 3795 per l in wild-type control mice
decreased lymphocyte cell number ( J:81054 )
• starting at 6 months of age, ~60% of G1 and G2 male hemizygotes are lymphopenic with a mean absolute number of lymphocytes equal to 2428 1978 per l versus 5352 2945 per l in wild-type control mice
decreased B cell number ( J:81054 )
• at 8 months of age, some G1 and G2 male hemizygotes exhibit a specific reduction in B lymphocytes (CD3 and B220 positive cells) relative to wild-type control mice, as revealed by flow cytometric analysis
decreased pre-B cell number ( J:81054 )
• BM colony-forming assays indicate a significant reduction of pre- B colony-forming units (CFU-preBs) relative to wild-type control mice
abnormal spleen morphology ( J:81054 )
• G1-G2 male hemizygotes show total effacement of the architecture of splenic tissue, with loss of red and white pulp areas
enlarged spleen ( J:81054 )
• G1-G2 male hemizygotes exhibit splenomegaly
abnormal bone marrow cell physiology ( J:81054 )
• G1 and G2 male hemizygotes exhibit bone marrow failure prior to the onset of disease

immune system
decreased leukocyte cell number ( J:81054 )
• starting at 6 months of age, ~60% of G1 and G2 male hemizygotes become mildly leukopenic as a result of lymphopenia, with a mean white blood cell count of 4526 3311 per l versus 8215 3795 per l in wild-type control mice
decreased lymphocyte cell number ( J:81054 )
• starting at 6 months of age, ~60% of G1 and G2 male hemizygotes are lymphopenic with a mean absolute number of lymphocytes equal to 2428 1978 per l versus 5352 2945 per l in wild-type control mice
decreased B cell number ( J:81054 )
• at 8 months of age, some G1 and G2 male hemizygotes exhibit a specific reduction in B lymphocytes (CD3 and B220 positive cells) relative to wild-type control mice, as revealed by flow cytometric analysis
decreased pre-B cell number ( J:81054 )
• BM colony-forming assays indicate a significant reduction of pre- B colony-forming units (CFU-preBs) relative to wild-type control mice
abnormal spleen morphology ( J:81054 )
• G1-G2 male hemizygotes show total effacement of the architecture of splenic tissue, with loss of red and white pulp areas
enlarged spleen ( J:81054 )
• G1-G2 male hemizygotes exhibit splenomegaly
lung inflammation ( J:81054 )
• G1 male hemizygotes show inflammatory cellular infiltrates in their lungs

respiratory system
lung inflammation ( J:81054 )
• G1 male hemizygotes show inflammatory cellular infiltrates in their lungs
increased lung carcinoma incidence ( J:81054 )
• ~25% of G1-G2 male hemizygotes (17-22 months of age) develop lung carcinomas versus less than 10% of wild-type mice (20-24 months of age)
abnormal pulmonary alveolus morphology ( J:81054 )
• fusion of the alveolar spaces
increased pulmonary alveolus wall thickness ( J:81054 )
• thickening of the alveolar walls
abnormal pulmonary alveolar parenchyma morphology ( J:81054 )
• G1 male hemizygotes exhibit disruption of the normal architecture of the lung parenchyma due to fusion of the alveolar spaces and thickening of the alveolar walls

renal/urinary system
glomerulosclerosis ( J:81054 )
• G1 male hemizygotes show a significant number of atrophic proximal tubules surrounded by sclerotic glomeruli
• glomerulosclerotic tufts display solidified areas and are adjacent to normal-appearing glomeruli
renal tubule atrophy ( J:81054 )
• a significant number of atrophic proximal tubules is observed
abnormal proximal convoluted tubule morphology ( J:81054 )
• G1 male hemizygotes show a significant number of atrophic proximal tubules surrounded by sclerotic glomeruli

neoplasm
increased pheochromocytoma incidence ( J:81054 )
• ~4% of G1-G2 male hemizygotes (17-22 months of age) develop pheochromocytomas versus 0% of wild-type mice (20-24 months of age)
increased B cell derived lymphoma incidence ( J:81054 )
• ~17% of G1-G2 male hemizygotes (17-22 months of age) develop B-cell lymphomas versus less than 4% of wild-type mice (20-24 months of age)
increased malignant tumor incidence ( J:81054 )
• 50% of G1-G2 male hemizygotes develop malignant tumors during their life-span
• common tumors include lung carcinomas and adenocarcinomas of the mammary gland; one case of renal cell carcinoma is observed
increased mammary adenocarcinoma incidence ( J:81054 )
• ~4% of G1-G2 male hemizygotes (17-22 months of age) develop mammary adenocarcinomas versus 0% of wild-type mice (20-24 months of age)
increased lung carcinoma incidence ( J:81054 )
• ~25% of G1-G2 male hemizygotes (17-22 months of age) develop lung carcinomas versus less than 10% of wild-type mice (20-24 months of age)
increased fibrosarcoma incidence ( J:81054 )
• ~4% of G1-G2 male hemizygotes (17-22 months of age) develop fibrosarcomas invading the skeletal muscle versus 0% of wild-type mice (20-24 months of age)

cellular
decreased telomere length ( J:81054 )
• 30% of early G4 male hemizygotes display a reduction of telomere length in primary B lymphocytes, as determined by flow-FISH analysis
• in addition, G4 male hemizygotes show a loss of telomere repeats on individual chromosome ends, as shown by quantitative-FISH analysis
• however, no changes in telomere length or in the relative number of telomere repeats are detected prior to G4
• reduced telomere length in early G4 hemizygotes is accompanied by a 40% decrease of telomerase activity in spleen-derived primary B lymphocytes along with a 1.2-fold reduction in mouse telomerase RNA levels
abnormal cell physiology ( J:81054 )
• B lymphocytes from G1 and G2 male hemizygotes display impaired rRNA pseudouridylation and ribosome function prior to the onset of dyskeratosis congenita
increased fibroblast apoptosis ( J:81054 )
• early passage MEFs derived from G2 male hemizygotes are hypersensitive to drugs that inhibit translation, and undergo apoptosis at a significantly higher rate than wild-type MEFs

adipose tissue
increased total body fat amount ( J:81054 )
• at 8 months of age, anemic G1 and G2 male hemizygotes show decreased BM cellularity along with a relative increase in adipose and fibrous tissue

integument
increased mammary adenocarcinoma incidence ( J:81054 )
• ~4% of G1-G2 male hemizygotes (17-22 months of age) develop mammary adenocarcinomas versus 0% of wild-type mice (20-24 months of age)
abnormal epidermis stratum granulosum morphology ( J:81054 )
• 7 of 25 G1 male hemizygotes display an enlarged granular layer, as identified with anti-filaggrin antibody
abnormal epidermis stratum spinosum morphology ( J:81054 )
• 7 of 25 G1 male hemizygotes show an expansion of the spinal layer with keratinocytes showing prominent nuclei
epidermal hyperplasia ( J:81054 )
• 7 of 25 G1 male hemizygotes epidermal hyperplastic changes due to an expansion of the nucleated cell layers
dyskeratosis ( J:81054 )
• 7 of 25 G1 male hemizygotes display dyskeratosis of the skin

growth/size/body
enlarged spleen ( J:81054 )
• G1-G2 male hemizygotes exhibit splenomegaly

Mouse Models of Human Disease
 DO ID OMIM ID(s) Ref(s)
dyskeratosis congenita DOID:2729 OMIM:PS127550
 J:81054




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory